retatrutide phase 3 2025 triple agonist glp-1 gip glucagon Retatrutide, a (GLP1, GIP, glucagon), just released 2 trial results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished From Obesity to Metabolic Health:

Improvement of Cognitive Function in Neurodegenerative Diseases: In conditions like Alzheimers and Parkinsons disease, Dihexas ability to promote neuron and synapse growth offers potential therapeutic benefits in slowing or possibly reversing cognitive decline within brain cells

Ashwagandha: Helps manage stress levels, which can contribute to hair health and reduce the appearance of gray hair

Balanced testosterone levels are key to male fertility, as they affect the quantity, shape, and motility of sperm

[DOI] [PubMed] 496.Evangelista L, et al

J Biol Sci

Kozmetik Formlasyonlar: stenen aydnlatc etkiye bal olarak genellikle %0.1 ila %2 konsantrasyonlarnda dahil edilir